Management Team

Executive Officers

Thomas W. Burns , , , President, Chief Executive Officer

Mr. Burns has served as our President, Chief Executive Officer and as a member of our Board of Directors since March 2002. Mr. Burns has also been a member of the board of directors of DOSE Medical Corporation since October 2009 and served as its chief executive officer and president from March 2010 until June 2015. Mr. Burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. Prior to joining our company, Mr. Burns led Eyetech Pharmaceuticals, Inc. (acquired by OSI Pharmaceuticals, Inc.) as its president and chief operating officer, and as a director. From 1990 to 1997, Mr. Burns served as senior vice president and general manager of Chiron Vision Corporation (acquired by Bausch & Lomb, Inc.), and then as vice president, global strategy and general manager, refractive surgery, of Bausch & Lomb from 1998 to 2000. Mr. Burns has also served as an entrepreneur in residence at Versant Ventures Management, LLC, an entity affiliated with one of our principal stockholders. Mr. Burns received a B.A. from Yale University.

Chris M. Calcaterra , , , Chief Operating Officer

Mr. Calcaterra has served as our chief operating officer since February 2017. He was previously our chief commercial officer, a position he had held since joining Glaukos in April 2008. Mr. Calcaterra has more than 25 years of experience in the ophthalmic medical technology industry. Prior to joining our Company, Mr. Calcaterra was senior vice president at Advanced Medical Optics, Inc. (acquired by Abbott Laboratories), and was responsible for its cataract business. Prior to that position, Mr. Calcaterra held increasingly responsible vice president positions in a variety of sales and marketing roles at Advanced Medical Optics, Inc., as well as its predecessor surgical division business at Allergan, Inc. Mr. Calcaterra has a B.S. from Miami University and an M.B.A. from Xavier University, and he was previously a board member of WaveTec Vision Systems, Inc. (acquired by Novartis)

Richard L. Harrison , , , Chief Financial Officer

Mr. Harrison has served as our chief financial officer since January 2008, and as our treasurer and secretary since July 2014. Mr. Harrison served as the chief financial officer of DOSE Medical Corporation from March 2010 until June 2015. From December 2005 to January 2008, Mr. Harrison served as the chief financial officer and executive vice president of Biolase Technology Inc. (now Biolase, Inc.), and from November 1994 to 2004, Mr. Harrison served as the chief financial officer and senior vice president, finance of Interpore Cross International (acquired by Biomet, Inc.), a public medical device company. Mr. Harrison worked for Kirschner Medical Corporation, a public manufacturer of orthopedic devices, in a variety of financial positions, including corporate controller from 1992 through 1994. Mr. Harrison is a Certified Public Accountant in Maryland (inactive status) and holds a B.A. from Towson University and an M.B.A. from Loyola College in Maryland.

Key Employees

Robert L. Davis , , , Senior Vice President, General Counsel

Robert L. Davis has served as our senior vice president and general counsel since June 2015. From April 2008 to May 2015, Mr. Davis served as senior vice president, general counsel and secretary for Targus Group International, Inc., a global designer, manufacturer and distributor of cases and accessories for mobile electronic devices. From December 1999 to April 2008, Mr. Davis served in various executive positions, including senior vice president, corporate development and assistant general counsel, with Meade Instruments Corp., a publicly traded designer, manufacturer and distributor of precision optical products. From September 1994 to December 1999, Mr. Davis was in private legal practice with the law firms of O’Melveny & Myers, LLP and Morrison & Foerster, LLP. Mr. Davis is an active member of the California State Bar, admitted in 1994, and holds both a B.A. and a J.D. from Brigham Young University.

Jeffrey M. Wells , , Pharm.D. , , Senior Vice President, Regulatory, Quality and Clinical Affairs

Jeffrey M. Wells, Pharm.D. has served as our senior vice president, regulatory, quality and clinical affairs since September 2008. Prior to joining our company, Mr. Wells was senior vice president of product development at BioForm Medical, Inc., a medical aesthetics firm. Prior to this, Mr. Wells was vice president, U.S. research and development at Santen Pharmaceutical Co., Ltd. Prior to this role, he held various positions with Santen, including vice president, clinical and regulatory affairs and project management for the United States and Europe, vice president, U.S. clinical affairs, and director of marketing. Prior to Santen, Mr. Wells held various marketing positions with Bausch & Lomb, Inc., wherehe launched Lotemax and several other ophthalmic products. Mr. Wells holds a B.S. and a B.A. from Ohio Northern University, a Masters in Management (M.B.A.) from the Kellogg Graduate School of Management at Northwestern University, and a Pharm.D. from the University of Florida. Mr. Wells also possesses a Regulatory Affairs Certification.

Michele M. Allegretto , , , Vice President, Human Resources

Michele M. Allegretto has served as our vice president, human resources since May 2015. From October 2005 to May 2015, Ms. Allegretto served as director global business human resources with Abbott Medical Optics, a global ophthalmic medical device division of Abbott Laboratories. From January 2002 to October 2005, Ms. Allegretto was director of human resources for The Wet Seal, Inc., a publicly traded national women’s retail chain. From April 1995 to December 2001, Ms. Allegretto served in several different leadership positions across three divisions of The Walt Disney Company, including the director recruitment for Walt Disney Studios. Ms. Allegretto holds a B.A. from San Diego State University and a master’s degree from California State University, Long Beach.

Sheree L. Aronson , , , Vice President, Investor Relations & Corporate Marketing

Sheree L. Aronson has served as our vice president, investor relations and corporate marketing since February 2017. She was previously our vice president, investor relations, a position she had held since joining Glaukos in June 2015. Prior to joining Glaukos, she consulted with various medical technology companies on strategic communications matters. From November 2009 to May 2013, Ms. Aronson was vice president of investor relations for Masimo Corporation, a provider of pulse oximetry and noninvasive monitoring technologies. From August 2003 to April 2009, Ms. Aronson led the investor relations, corporate communications, and market research functions at Advanced Medical Optics, Inc. (acquired by Abbott Laboratories). Her previous experience includes financial communications positions at Fleishman-Hillard, Inc., Apria Healthcare, MTI Technology and Foodmaker, Inc. Ms. Aronson holds a B.S. degree in journalism from Oklahoma State University.

David S. Haffner , , , Senior Vice President, New Technologies

David S. Haffner has served as our senior vice president, new technologies since February 2017. He was previously our vice president, product development, a position he had held since joining Glaukos in February 2001. Immediately prior to joining our company, Mr. Haffner consulted to the medical industry in the areas of medical device and pharmaceutical product development, with emphasis on mechanical systems for pharmaceutical drug delivery. Prior to this, he spent over 10 years at Allergan, Inc. leading teams and departments in several divisions, including surgical products, pharmaceuticals, and worldwide operations. Mr. Haffner has directed several multi-million dollar programs in both research and development and operations involving development and commercialization of ophthalmic products and technologies targeted at cataract, glaucoma, dry eye and nasal disease groups. The scope of his work has spanned a broad diversity of technical disciplines including operations management, process development, site construction, validation, injection molding, automated assembly, packaging, product design, engineering analysis, and industrial design. Mr. Haffner holds a B.S. from California State University, Long Beach

Harold A. Heitzmann , , Ph.D. , , Senior Vice President, Applied Research & Engineering

Harold A. Heitzmann has served as our senior vice president, applied research and engineering since February 2017. He was previously our vice president, applied research, a position he had held since joining Glaukos in January 2007. He has over 30 years' experience in development of medical devices at five startup companies and at Edwards Lifesciences Corporation, including three previous positions as vice president. Dr. Heitzmann has led development of commercial products for blood gas monitoring, angioplasty, intracranial pressure monitoring, electrophysiology, coronary stenting, thrombectomy, venous oxygen saturation monitoring, and antimicrobial catheterization. He holds 18 issued U.S. patents and has taught at University of California, Irvine Extension in the Clinical Trials and Medical Product Development certificate programs. Dr. Heitzmann holds a B.A. from Cornell University and a Ph.D. in Molecular Biophysics and Biochemistry from Yale University, where he co-invented avidin-biotin staining for microscopy.

Contact Investor Relations

Glaukos Corporation
229 Avenida Fabricante
San Clemente, CA 92672

Telephone: 949-367-9600 ext 371
Fax: 949-367-9984
Email: investors@glaukos.com